CTKBCytek Biosciences, Inc.

Nasdaq cytekbio.com


$ 5.43 $ 0.21 (4.02 %)    

Thursday, 05-Sep-2024 15:16:02 EDT
QQQ $ 459.86 $ 0.43 (0.09 %)
DIA $ 407.95 $ -1.96 (-0.48 %)
SPY $ 548.56 $ -1.34 (-0.24 %)
TLT $ 99.56 $ 0.56 (0.57 %)
GLD $ 232.35 $ 1.92 (0.83 %)
$ 5.44
$ 5.26
$ 5.43 x 200
$ 5.44 x 127
$ 5.22 - $ 5.45
$ 3.80 - $ 9.87
448,325
na
715.39M
$ 1.07
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2024 06-30-2024 10-Q
2 05-08-2024 03-31-2024 10-Q
3 03-13-2024 12-31-2023 10-K
4 11-14-2023 09-30-2023 10-Q
5 08-08-2023 06-30-2023 10-Q
6 05-09-2023 03-31-2023 10-Q
7 03-01-2023 12-31-2022 10-K
8 11-09-2022 09-30-2022 10-Q
9 08-10-2022 06-30-2022 10-Q
10 05-11-2022 03-31-2022 10-Q
11 03-17-2022 12-31-2021 10-K
12 11-12-2021 09-30-2021 10-Q
13 09-02-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 piper-sandler-maintains-overweight-on-cytek-biosciences-lowers-price-target-to-8

Piper Sandler analyst David Westenberg maintains Cytek Biosciences (NASDAQ:CTKB) with a Overweight and lowers the price targ...

 cytek-biosciences-narrows-fy24-revenue-outlook-from-203m---213m-to-203m---210m-est-208801m-now-expects-to-report-net-loss-in-the-single-digit-millions-for-fy24

In addition, Cytek expects to report a net loss in the single digit millions for the full year 2024 (prior view: report positiv...

 cytek-biosciences-q2-2024-gaap-eps-008-misses-003-estimate-sales-46617m-miss-49526m-estimate

Cytek Biosciences (NASDAQ:CTKB) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $...

 cytek-biosciences-automates-panel-design-with-new-intelligent-algorithm-expanding-the-capabilities-of-the-panel-builder-tool-within-its-cytek-cloud-digital-ecosystem-with-the-addition-of-spectropanel-tool

Today Cytek Biosciences, Inc. (NASDAQ:CTKB) announced that it has developed a revolutionary tool to automate panel design. The ...

 piper-sandler-maintains-overweight-on-cytek-biosciences-lowers-price-target-to-85

Piper Sandler analyst David Westenberg maintains Cytek Biosciences (NASDAQ:CTKB) with a Overweight and lowers the price targ...

 cytek-biosciences-q1-2024-adj-eps-005-misses-004-estimate-sales-44900m-beat-43586m-estimate

Cytek Biosciences (NASDAQ:CTKB) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $...

 cytek-biosciences-names-william-mccombe-chief-financial-officer-reaffirms-2024-revenue-outlook-of-203m-213m-vs-20786m-est

Experienced executive with extensive background as CFO for global corporations across dynamic sectors Cytek reaffirms 2024 outl...

 piper-sandler-maintains-overweight-on-cytek-biosciences-lowers-price-target-to-10

Piper Sandler analyst David Westenberg maintains Cytek Biosciences (NASDAQ:CTKB) with a Overweight and lowers the price targ...

 tesla-spirit-airlines-new-york-community-bancorp-and-other-big-stocks-moving-lower-on-monday

U.S. stocks were lower, with the Dow Jones index falling around 80 points on Monday.

 cytek-biosciences-inc-files-for-non-timely-10-k-with-the-us-sec-sees-to-report-un-remediated-material-weaknesses-in-form-10-k-for-quarter-ended-sept-30-2023

- SEC Filing

 why-butterfly-network-shares-are-trading-lower-by-22-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed four...

 goldman-sachs-maintains-buy-on-cytek-biosciences-raises-price-target-to-10

Goldman Sachs analyst Matthew Sykes maintains Cytek Biosciences (NASDAQ:CTKB) with a Buy and raises the price target from $9...

 cytek-biosciences-q4-sales-5860m-beat-5658m-estimate

Cytek Biosciences (NASDAQ:CTKB) reported quarterly sales of $58.60 million which beat the analyst consensus estimate of $56.58 ...

 earnings-scheduled-for-february-28-2024

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenu...

 cytek-biosciences-inks-agreement-with-centre-for-genomic-regulation-and-pompeu-fabra-university-to-drive-scientific-discoveries-no-terms-disclosed

Under the terms of the agreement, Cytek will provide new, state-of-the-art spectral cytometry platforms – along with trained su...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION